Options
In vitro study of the interaction of heregulin-functionalized magnetic-optical nanorods with MCF7 and MDA-MB- 231 cells
Date Issued
2014-09
Date Available
2017-03-28T17:15:44Z
Abstract
Multifunctional nanoparticles that actively target specific cells are promising tools for cancer diagnosis and therapy. In this article we review the synthesis and surface chemistry of Fe–Au nanorods and their characterization using microscopy. The diameter of the rods used in this study was selected to be 150–200 nm so that they did not enter the cells. The 80 nm-long Au tips of the nanorods were functionalized with heregulin (HRG), and the micron-long Fe portion was coated with a poly(ethylene glycol) monolayer to minimize non-specific interactions. Nanorods functionalized with HRG were found to preferentially bind to MCF7 cells that express high levels of the receptor tyrosine-protein kinase ErbB2/3. Magnetic tweezers measurements were used to characterize the kinetic properties of the bond between the HRG on the rods and ErbB2/3 on the surface of the cells. The strong magnetization of Fe–Au nanorods makes them excellent candidates for in-vitro and in-vivo imaging, and magnetic therapeutic applications targeting cancer cells in circulation.
Sponsorship
Science Foundation Ireland
Other Sponsorship
Erasmus Mundus Gulf Countries Postdoctoral Fellowship
Marie Curie Intra-European Fellowship
Type of Material
Journal Article
Publisher
Royal Society of Chemistry
Journal
Faraday Discussions
Volume
175
Issue
189
Start Page
201
Copyright (Published Version)
2014 The Royal Society of Chemistry
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
Name
Faraday_Discussion_175_2014_-_In_vitro_study_of_the_interaction_of_heregulin.pdf
Size
6.9 MB
Format
Owning collection
Scopus© citations
2
Acquisition Date
Apr 17, 2024
Apr 17, 2024
Views
1851
Last Month
3
3
Acquisition Date
Apr 17, 2024
Apr 17, 2024
Downloads
652
Last Week
1
1
Last Month
3
3
Acquisition Date
Apr 17, 2024
Apr 17, 2024